Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,026 INR | -1.48% | -2.41% | +20.19% |
Sales 2024 * | 121B 1.45B | Sales 2025 * | 140B 1.68B | Capitalization | 290B 3.48B |
---|---|---|---|---|---|
Net income 2024 * | 33.36B 400M | Net income 2025 * | 11.13B 134M | EV / Sales 2024 * | 2.55 x |
Net Debt 2024 * | 19.84B 238M | Net cash position 2025 * | 3.08B 36.96M | EV / Sales 2025 * | 2.04 x |
P/E ratio 2024 * |
58.1
x | P/E ratio 2025 * |
23.8
x | Employees | 15,556 |
Yield 2024 * |
0.23% | Yield 2025 * |
0.28% | Free-Float | 49.03% |
Latest transcript on Glenmark Pharmaceuticals Limited
1 day | -1.48% | ||
1 week | -2.41% | ||
Current month | +7.09% | ||
1 month | +11.49% | ||
3 months | +16.75% | ||
6 months | +29.41% | ||
Current year | +20.19% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | - | |
Chief Executive Officer | 54 | 98-10-11 | |
Ulhas Dhuppad
PSD | President | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 59 | 20-08-13 | |
Cherylann Pinto
BRD | Director/Board Member | 56 | 99-10-05 |
Chief Executive Officer | 54 | 98-10-11 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 4 M€ | -4.41% | - | |
0.01% | 117 M€ | -1.55% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 1,026 | -1.48% | 762,705 |
24-04-18 | 1,042 | -1.72% | 1,139,829 |
24-04-16 | 1,060 | +1.53% | 425,482 |
24-04-15 | 1,044 | -0.74% | 586,620 |
24-04-12 | 1,052 | +0.81% | 980,800 |
Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+20.19% | 3.52B | |
+20.91% | 43.54B | |
+16.96% | 21.74B | |
+9.05% | 13.53B | |
+7.98% | 13.02B | |
+33.80% | 11.28B | |
-11.05% | 6.99B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+6.64% | 5.09B |
- Stock Market
- Equities
- GLENMARK Stock